Pharmacoeconomics of opioid therapy for chronic non-malignant pain

Expert Opin Pharmacother. 2002 Mar;3(3):229-35. doi: 10.1517/14656566.3.3.229.

Abstract

Chronic non-malignant pain (CNMP) is widely prevalent and associated with significant costs. Costs related to chronic pain include medical services and medications, treatment of medication-related toxicity and work absenteeism. The use of non-narcotic analgesics is associated with inadequate pain-relief for many patients, as well as significant and costly organ toxicity. When used appropriately and judiciously, opioid medications can be a useful addition to the treatment plan for patients with CNMP. Opioids can provide long-term, safe and cost-effective pain relief.

Publication types

  • Review

MeSH terms

  • Analgesics, Opioid / adverse effects
  • Analgesics, Opioid / economics*
  • Analgesics, Opioid / therapeutic use*
  • Chronic Disease
  • Humans
  • Pain / drug therapy*
  • Pain / economics*
  • Pain / epidemiology

Substances

  • Analgesics, Opioid